Wikipedia -WSS

Wikipedia

author：leisure time 2025-08-10 11:42:20 - browse：44

An AstraZeneca sign at ESMO in Madrid. — An AstraZeneca ad at ESMO 2023 in Madrid. Andrew Joseph/STAT

MADRID — Questions about one of AstraZeneca’s key cancer drug candidates — and the dribs and drabs that have come out about its performance — have been dogging the company for months.

On Monday, data presented here from a trial of the drug in advanced non-small cell lung cancer provided at least a fuller look. While the results assuaged some of the safety fears that flared when initial information was released over the summer, they only heightened concerns about the drug’s ability to outperform standard chemotherapy — though they perhaps pointed to an opportunity for the drug in a subset of patients.

The trial, detailed here in a prime session at the annual meeting of the European Society for Medical Oncology, is testing a therapy called datopotamab deruxtecan, or Dato-DXd, in advanced or metastatic non-small cell lung cancer in patients who already tried at least first-line treatments. Patients were randomized to either receive chemotherapy or Dato-DXd, which AstraZeneca is developing with Daiichi Sankyo.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Study links childhood stress with decline in older age

WSS

Physician subsidies by hospitals soar in wake of No Surprises Act

Florida officials tell state schools to teach AP Psychology 'in its entirety'

It costs an awful lot of money to give away a kidney

Flint parents haunted by uncertainty, fears of lead poisoning

Biden's order seeks to regulate AI risk without stifling innovation

Physicians aren't 'burning out.' They're suffering from moral injury

focus

Wikipedia

leisure time

Trump demands the U.S. pay no more for drugs than other countries … again

'Null' research findings aren't empty of meaning. Let's publish them

Supreme Court strikes down use of affirmative action

The FDA weighs the risks of candy

Malaria cases in Florida and Texas: Here’s what you need to know

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Activists slam private health insurers over coverage restrictions

CDC recommends rationing of RSV shot due to shortages

State Dept. review finds Biden bears some blame for Afghanistan failures

The FDA weighs the risks of candy

focus

Pharma showers House GOP doctor with campaign cash

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

2 officers injured in shooting in Orlando, police say

Medtronic CEO on promising devices for diabetes, hypertension

Eli Lilly to pay $200M for Beam’s stake in gene

Meta's Zuckerberg and Chan on track to put $50 billion into science

hotspot

hotspot

Wikipedia

entertainment